Literature DB >> 16924108

OX40 ligand shuts down IL-10-producing regulatory T cells.

Tomoki Ito1, Yui-Hsi Wang, Omar Duramad, Shino Hanabuchi, Olivia A Perng, Michel Gilliet, F Xiao-Feng Qin, Yong-Jun Liu.   

Abstract

IL-10-producing CD4(+) type 1 regulatory T (Tr1) cells play a critical role in the maintenance of peripheral tolerance. Although immunosuppressive drugs, cytokines, costimulatory molecules, and immature dendritic cells are implicated in the induction of Tr1 cells, the signals that negatively regulate the generation and function of Tr1 cells have been elusive. We report that OX40 ligand (OX40L) completely inhibited the generation of IL-10-producing Tr1 cells from naïve and memory CD4(+) T cells induced by the immunosuppressive drugs dexamethasone and vitamin D3. This unique function of OX40L was not shared by two costimulatory TNF family members, GITR ligand and 4-1BB ligand. OX40L strongly inhibited the generation of IL-10-producing Tr1 cells induced by two physiologic stimuli, the inducible costimulatory ligand and immature dendritic cells. In addition, OX40L strongly inhibited IL-10 production and suppressive function of differentiated IL-10-producing Tr1 cells. These two novel functions of OX40L shed light on the mechanism by which OX40/OX40L regulates immunity and tolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924108      PMCID: PMC1559766          DOI: 10.1073/pnas.0603107103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins.

Authors:  Neil C Rogers; Emma C Slack; Alexander D Edwards; Martijn A Nolte; Oliver Schulz; Edina Schweighoffer; David L Williams; Siamon Gordon; Victor L Tybulewicz; Gordon D Brown; Caetano Reis e Sousa
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

2.  Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance.

Authors:  Stephanie Dillon; Sudhanshu Agrawal; Kaustuv Banerjee; John Letterio; Timothy L Denning; Kyra Oswald-Richter; Deborah J Kasprowicz; Kathryn Kellar; Jeff Pare; Thomas van Dyke; Steven Ziegler; Derya Unutmaz; Bali Pulendran
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

3.  Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26.

Authors:  Haluk B Oral; Sergei V Kotenko; Mustafa Yilmaz; Orlando Mani; Judith Zumkehr; Kurt Blaser; Cezmi A Akdis; Mübeccel Akdis
Journal:  Eur J Immunol       Date:  2006-02       Impact factor: 5.532

4.  Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL.

Authors:  Lena Serghides; Jacob Bukczynski; Tao Wen; Chao Wang; Jean-Pierre Routy; Mohamed-Rachid Boulassel; Rafick-Pierre Sekaly; Mario Ostrowski; Nicole F Bernard; Tania H Watts
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 5.  TNF/TNFR family members in costimulation of T cell responses.

Authors:  Tania H Watts
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

6.  Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction.

Authors:  Christine E Loscher; Eve Draper; Olive Leavy; Dermot Kelleher; Kingston H G Mills; Helen M Roche
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

7.  Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment.

Authors:  Takanori So; Jianxun Song; Katsuji Sugie; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-24       Impact factor: 11.205

Review 8.  Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.

Authors:  C M Hawrylowicz; A O'Garra
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

9.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

10.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.

Authors:  Megan K Levings; Silvia Gregori; Eleonora Tresoldi; Sabrina Cazzaniga; Chiara Bonini; Maria Grazia Roncarolo
Journal:  Blood       Date:  2004-10-12       Impact factor: 22.113

View more
  85 in total

Review 1.  Immunotherapies for bladder cancer: a new hope.

Authors:  Farhad Fakhrejahani; Yusuke Tomita; Agnes Maj-Hes; Jane B Trepel; Maria De Santis; Andrea B Apolo
Journal:  Curr Opin Urol       Date:  2015-11       Impact factor: 2.309

2.  Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.

Authors:  Damien Bresson; Georgia Fousteri; Yulia Manenkova; Michael Croft; Matthias von Herrath
Journal:  J Autoimmun       Date:  2011-11-06       Impact factor: 7.094

3.  Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma.

Authors:  Halvor S McGee; Devendra K Agrawal
Journal:  Am J Respir Crit Care Med       Date:  2009-05-15       Impact factor: 21.405

4.  OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.

Authors:  Naomi Kitamura; Satoshi Murata; Tomoyuki Ueki; Eiji Mekata; R Todd Reilly; Elizabeth M Jaffee; Tohru Tani
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

Review 5.  Sjögren's syndrome: an old tale with a new twist.

Authors:  Byung Ha Lee; Mauro A Tudares; Cuong Q Nguyen
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

6.  Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Authors:  Kui Shin Voo; Myriam Foglietta; Elena Percivalle; Fuliang Chu; Durga Nattamai; Megan Harline; Seung-Tae Lee; Laura Bover; Heather Y Lin; Veerabhadran Baladandayuthapani; David Delgado; Amber Luong; R Eric Davis; Larry W Kwak; Yong-Jun Liu; Sattva S Neelapu
Journal:  Int J Cancer       Date:  2014-05-12       Impact factor: 7.396

7.  OX40 costimulation turns off Foxp3+ Tregs.

Authors:  Minh Diem Vu; Xiang Xiao; Wenda Gao; Nicolas Degauque; Ming Chen; Alexander Kroemer; Nigel Killeen; Naoto Ishii; Xian Chang Li
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

8.  Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.

Authors:  Michael D Oberst; Catherine Augé; Chad Morris; Stacy Kentner; Kathy Mulgrew; Kelly McGlinchey; James Hair; Shino Hanabuchi; Qun Du; Melissa Damschroder; Hui Feng; Steven Eck; Nicholas Buss; Lolke de Haan; Andrew J Pierce; Haesun Park; Andrew Sylwester; Michael K Axthelm; Louis Picker; Nicholas P Morris; Andrew Weinberg; Scott A Hammond
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

9.  A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han population.

Authors:  Sheng-Quan Zhang; Jian-Wen Han; Liang-Dan Sun; Wen-Sheng Lu; Xian-Yong Yin; Xue-Jun Zhang; Sen Yang
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

10.  Molecular Profiling of Exceptional Responders to Cancer Therapy.

Authors:  Marijo Bilusic; Daniel Girardi; Yan Zhou; Kyungsuk Jung; Jianming Pei; Michael Slifker; Qingrong Chen; Daoud Meerzaman; Katherine Alpaugh; Denise Young; Douglas Flieder; Phillip Gray; Elizabeth Plimack
Journal:  Oncologist       Date:  2020-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.